Articles From: Individuals Cautious on China Trading Link to Allergan, Actavis Near Deal -- 3rd Update


2014/11/17
By Chao Deng Individuals remained cautious Monday, as global fund managers snapped up Chinese stocks on the first day of trading of a program that allows international investors to buy shares of companies trading in Shanghai.
Sign-up for Individuals Cautious on China Trading Link investment picks
2014/11/17
By Laura He, MarketWatch Hong Kong and Shanghai end lower as Stock Connect starts HONG KONG (MarketWatch) -- Japanese stocks suffered their worst daily drop in more than three months, as the economy entered a recession unexpectedly in the third quarter.
Sign-up for ASIA MARKETS: Japanese Stocks Suffer As Economy Falls Into Recession investment picks
2014/11/17
By Laura He, MarketWatch Hong Kong and Shanghai end lower as Stock Connect starts HONG KONG (MarketWatch) -- Japanese stocks suffered their worst daily drop in more than three months, as the economy entered a recession unexpectedly in the third quarter.
Sign-up for Japanese stocks suffer as economy falls into recession investment picks
2014/11/17
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks fell Monday, losing ground alongside other global markets after Japan's economy unexpectedly fell into recession.
Sign-up for U.K. stocks fall after Japan GDP shock; AstraZeneca drops investment picks
2014/11/17
By Natalia Drozdiak FRANKFURT--
Sign-up for Pfizer, Germany's Merck to Develop Tumor Treatment investment picks
By Natalia Drozdiak FRANKFURT --
Sign-up for Pfizer, Merck strike deal to develop cancer tumor treatment investment picks
2014/11/17
By Nicholas Bariyo Special to DOW JONES NEWSWIRES KAMPALA, Uganda--Lebanon-based telecommunications company Africell plans to invest up to $150 million to improve the network of its recently acquired Ugandan unit, Orange Uganda Ltd., over the next three years, a company executive said Monday.
Sign-up for Africell Plans to Invest $150 Million to Upgrade Uganda Operations -CEO investment picks
GNCC Capital, Inc. (OTC:GNCP) (“The Company”) confirms that the following corporate actions have been executed, as follows: RATIONALE FOR THESE ACTIONS: The Company has terminated its previous policy of remuneration through the use of “Free Trading” shares of Common Stock and with immediate effect.
Sign-up for GNCC Capital, Inc. Announces Various Immediate Corporate Actions investment picks
HAIFA, Israel , November 17, 2014 /PRNewswire/ -- Elbit Systems Ltd.
Sign-up for Elbit Systems MUSIC™ Self-Protection DIRCM Solution Marks Another Milestone, This Time in Germany: Elbit Systems Awarded a Contract to Supply DIRCM Systems for the German Air Force's New A400M Aircraft investment picks
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the completion of a method development project conducted in partnership with GlaxoSmithKline plc (GSK) to evaluate the impact of unifying mobile health (mHealth) devices with cloud-based technologies in a clinical trial setting.
Sign-up for Medidata Collaborates with GlaxoSmithKline on Mobile Health Initiative to Test Novel Technology for Clinical Trial Optimization investment picks
2014/11/17
By Wayne Arnold Georgina "Gina" Rinehart, Australia's wealthiest person, has apparently seen the future.
Sign-up for Rinehart's Formula For Success: Feed the Babies -- Barron's Asia investment picks
2014/11/17
By Rory Gallivan LONDON--TalkTalk Telecom Group PLC (TALK.LN) Monday announced a cooperation agreement with Telefonica SA's U.K. arm that will enable TalkTalk to offer high speed mobile connections to U.K. customers.
Sign-up for TalkTalk in Mobile Cooperation Agreement with Telefonica investment picks
LONDON--Microchip Technology Incorporated (MCHP) said Monday it has terminated talks with CSR PLC (CSR.LN), and doesn't intend to make an offer for the chip designer.
Sign-up for Microchip Technology Ends Offer Talks With CSR; No Plans to Make Bid investment picks
2014/11/17
By Inti Landauro PARIS--Valeant Pharmaceuticals International Inc. (VRX.T) is to buy the U.S. ophthalmic diagnostics unit of French biotech firm Nicox SA (COX.FR) for up to $20 million, the French firm said Monday in a statement.
Sign-up for Valeant Buys Nicox's Ophtalmic Diagnostics for Up to $20 Million investment picks
2014/11/17
By Ian Walker LONDON--Reckitt Benckiser Group PLC (RB.LN) said Monday it expects its pharmaceutical unit--Indivior PLC--to start trading on the London Stock Exchange on Dec.
Sign-up for Reckitt Benchiser to Float Pharma Unit Indivior on Dec 23 investment picks
2014/11/17
By Jens Hansegard STOCKHOLM--Swedish clothing retailer Hennes & Mauritz (HM-B.SK) Monday reported 14% higher sales in October than in the same month last year.
Sign-up for Hennes & Mauritz October Sales +14% investment picks
2014/11/17
By Andrew Morse ZURICH --
Sign-up for More Than Three-Quarters of Nobel Biocare Shares Committed to Buyout Offer investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159279&ProfileId=051205&sourceType=1 BAIE VERTE, NL --
Sign-up for Rambler and Maritime Agree to Evaluate the Viability of Restarting the Past Producing Hammerdown Gold Mine investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159289&ProfileId=051205&sourceType=1 ABERDEENSHIRE, UNITED KINGDOM --
Sign-up for Xcite Energy Limited Memorandum of Understanding With China Oilfield Services Limited investment picks
SEATTLE , Nov.
Sign-up for CTI BioPharma to Present at the Upcoming Investor Conferences investment picks
2014/11/16
By P.R. Venkat Singapore conglomerate Keppel Corp.'s unit, which is looking to raise over 500 million Singapore dollars (US$400 million) in an initial public offering of its data centers, has secured about 10 cornerstone investors for the deal, people with knowledge of the matter said Monday.
Sign-up for Keppel Unit Secures Key Investors for IPO investment picks
2014/11/16
By Qu Yunxu BEIJING (Caixin Online) -- Alibaba Group Holding Ltd.'s (BABA) annual e-commerce frenzy smashed last year's record, but company executives were not exactly ecstatic.
Sign-up for Alibaba and the truth behind the Singles Day sales numbers investment picks
2014/11/16
By Matt Wirz Ukraine's deputy prime minister was in a bind when he came to the San Mateo, Calif., office of mutual-fund manager Michael Hasenstab in January 2013.
Sign-up for Michael Hasenstab Bets Big in Controversial Places investment picks
2014/11/16
He made a huge profit as Ireland and Poland muddled through the crisis--and gained a reputation among government leaders as a white-knight investor.
Sign-up for Michael Hasenstab Bets Big in Controversial Places -2- investment picks
2014/11/16
By Gregor Stuart Hunter Investors poured money into China's stock market Monday on the first day of trading in a program that opened up the country's markets to trading through Hong Kong.
Sign-up for Money Surges Into Shanghai Stocks on Stock Connect's First Day -- Update investment picks
AUSTIN, Texas , Nov.
Sign-up for Hanger Postpones Release of Third Quarter 2014 Financial Results investment picks
2014/11/16
By Jonathan D.
Sign-up for Allergan, Actavis Near Deal -- 3rd Update investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Individuals Cautious on China Trading Link to Allergan, Actavis Near Deal -- 3rd Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent